During the past decade, Mahavir Cancer Sansthan conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mahavir Cancer Sansthan" are "Non-Squamous Non-Small Cell Lung Cancer" (1 trials) and "Non-small-cell Lung Cancer" (1 trials). Many other conditions were trialed in "Mahavir Cancer Sansthan" in a lesser frequency.

Most popular intervention types in "Mahavir Cancer Sansthan" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel plus bavituximab or placebo" (1 trials), "Paclitaxel / Carboplatin" (1 trials) and "bavituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mahavir Cancer Sansthan" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mahavir Cancer Sansthan". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mahavir Cancer Sansthan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mahavir Cancer Sansthan, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".